Cerevel Corp (CERE) Bozor qiymatining balans qiymatiga nisbati
Cerevel Therapeutics (CERE) dunyodagi eng yirik farmatsevtika yetakchilari bilan hamkorlikda neyropsixiatriya sohasidagi innovatsiyalarni ilgari surmoqda. Bozor qiymatining balans qiymatidan yuqori ekanligi ushbu sheriklik dinamikasini aniq aks ettiradi va joriy ko'rsatkich 14.42 darajasida turibdi. Qiymat o'sishi AbbVie tomonidan sotib olinishi va shizofreniya davolash usullarining muvaffaqiyati bilan ta'minlanmoqda, laboratoriyalarning modernizatsiyasi esa yangi klinik dori partiyalarining ishlab chiqarilishini kafolatlaydi.
Cerevel Therapeutics Inc (CERE) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Cerevel Therapeutics|CERE - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Cerevel|CERE - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Cerevel|CERE - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Cerevel Therapeutics|Tezkor likvidlik cerevel.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Cerevel Therapeutics - CERE
Cerevel Therapeutics (CERE) markaziy nerv tizimi kasalliklari va Parkinson kasalligini davolash uchun innovatsion dori vositalarini ishlab chiqishga ixtisoslashgan. Ushbu ko'rsatkich biznesning bozor qiymatini uning sof aktivlari bilan solishtirib, bozor kutimlari va balans qiymati o'rtasidagi farqni miqdoriy baholaydi. Ushbu koeffitsient moliyaviy barqarorlikning barometri vazifasini o'taydi, bunda past qiymatlar xavfsizlik zaxirasi mavjudligidan dalolat beradi. Biroq, chuqur chegirma daromadlilik bilan bog'liq muammolarni ko'rsatishi mumkin. Narxning balans qiymatiga nisbatini tahlil qilish orqali investor sog'liqni saqlash giganti AbbVie tomonidan sotib olinish ehtimoli oldidan aktivlarning real qiymatini baholaydi.
Asosiy raqobatchilar
BIIB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti neurocrine.com (NBIX)|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited|Kapitallashuvning balans qiymatiga nisbati AXSM (Axsome)|Bozor kapitallashuvining balans qiymatiga nisbati ACAD|XENE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Viking Therapeutics - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati supernus.com SUPN|CPRX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati DNLI (Denali)|Harmony Pharma (HRMY) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Biohaven Corp (BHVN)|AMLX (Amylyx Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati trevitherapeutics.com (TRVI)|Bozor kapitallashuvining balans qiymatiga nisbati PRAX|AVXL - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati CeriBell Corp CBLL|Balans qiymatiga nisbatan bozor qiymati PRTA|Alector Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti annexonbio.com|OMER (omeros.com) - Kapitallashuvning sof aktivlarga nisbati|NGNE (Neurogene Inc) - Bozor qiymatining balans qiymatiga nisbati|ACIU (AC Immune Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Voyager Corp VYGR|Bozor qiymatining balans qiymatiga nisbati Neumora Therapeutics (NMRA)|Bozor qiymatining balans qiymatiga nisbati SCLX (scilexholding.com)|Tevogen Bio - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati ACOG|CGTX: Kapitallashuvning sof aktivlarga nisbati|Inhibikase Pharma - Bozor kapitallashuvining balans qiymatiga multiplikatori|SAVA: Bozor kapitallashuvining balans qiymatiga nisbati|Assertio - Balans qiymatiga nisbatan bozor qiymati|COYA (Coya Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti VistaGen Therapeutics Inc VTGN|Bozor qiymatining balans qiymatiga nisbati Ovid Therapeutics Inc. (OVID)|ABOS (Acumen Pharmaceuticals, Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CRVO (CervoMed Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati Alterity Therapeutics Ltd. ATHE|CLNN - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi PEPG|JUNS: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Relmada Corp (RLMD)|Kapitallashuvning sof aktivlarga nisbati ANVS|Bozor kapitallashuvining balans qiymatiga nisbati Grace Tx|Kapitallashuvning sof aktivlarga nisbati AIFF (Firefly Neuroscience)|Bozor kapitallashuvining balans qiymatiga multiplikatori KLTO|Bozor kapitallashuvining balans qiymatiga nisbati NRSN (NeuroSense Therapeutics Ltd.)|Balans qiymatiga nisbatan bozor kapitallashuvi Reviva Pharmaceuticals, Inc. (RVPH)|MetaVia, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|neuraxis.com (NRXS) - Kapitallashuvning sof aktivlarga nisbati|heliusmedical.com (HSDT) - Bozor qiymatining balans qiymatiga nisbati|PASG - Balans qiymatiga nisbatan bozor kapitallashuvi|NEUP (Neuphoria Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Minerva (NERV)|Bozor kapitallashuvining balans qiymatiga nisbati ATHA|ADXN - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Alzamend Neuro ALZN|Balans qiymatiga nisbatan bozor qiymati CYCN|Protagenic - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Pasithea Therapeutics|cortigent.com (CRGT) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati ATXI|BCLI (BrainStorm Cell Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Cara Therapeutics Inc. CARA|Kapitallashuvning sof aktivlarga nisbati CHRO (Chromocell Therapeutics Corporation)|Bozor kapitallashuvining balans qiymatiga nisbati eliemtx.com (ELYM)|Bozor qiymatining balans qiymatiga nisbati Intra-Cellular Therapies, Inc. ITCI|Balans qiymatiga nisbatan bozor qiymati LBPH|MRNS - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti NKGen Biotech Inc|NRBO: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Sage Therapeutics Inc|SNPX (Synaptogenix, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti trevena.com TRVN|Bozor qiymatining balans qiymatiga nisbati Vigil Neuroscience (VIGL)|WENA (anewmeds.com) - Balans qiymatiga nisbatan bozor qiymati